Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Merck & Co. divulges coagulation factor XIa inhibitors

Dec. 3, 2021

Accutar Biotechnology patents EGFR and/or HER2 inhibitors

Dec. 3, 2021

Shanghai Zheye Biotechnology divulges new SGLT-1 inhibitors

Dec. 2, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical Group presents SOS1 inhibitors

Dec. 2, 2021

Glixogen Therapeutics identifies GLI1 inhibitors

Dec. 2, 2021

Suzhou Zelgen Biosciences synthesizes new GTPase KRAS mutant inhibitors

Dec. 2, 2021

Ube Industries patents integrin alphav antagonists

Dec. 2, 2021

Arbutus Biopharma synthesizes new HBV and HDV antivirals

Dec. 1, 2021

Orion identifies new CYP11A1 inhibitors

Dec. 1, 2021

Quretech Bio presents compounds for Gram-positive bacterial infections

Dec. 1, 2021

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...